Viridian Therapeutics Inc - VRDN - stock price prediction, stock price target, analyst ratings from 18 analysts

Viridian Therapeutics Inc has a share price target of US$ 42, revenue growth forecast of 11.3%, and profit growth estimate of -19.7% for FY26, based on top 18 analyst calls.